GynecologyGynecology2079-56962079-5831Consilium Medicum28599Research ArticleThe possibility of human placenta extract in the treatment of symptoms genitourinary syndrome in postmenopausal womenOrazovM Romekan@mail.ruKhamoshinaM Bmbax999@yandex.ruBebnevaT Nbebn@mail.ruPolicarpovaS R-People’s Friendship University of RussiaRussian Society of Organic, Tissue and Placental Therapy15022017191273009042020Copyright © 2017, Consilium Medicum2017Article is devoted an actual problem of modern gynecology - correction of the symptoms genitourinary syndrome (GUS), which has important medical and social importance. In addition to traditional hormone therapy, modern medicine has a broad range of metabolic substances, antioxidants and reparants to treat women with clinical manifestations of GUS. In this prospective study were 62 women aged up to 60 years in postmenopausal women with clinical symptoms of GUS, for the comprehensive treatment which the metabolic therapy was used the Melsmon (human placenta extract for subcutaneous injection).The results of the study demonstrated high clinical efficiency of the use of this therapy for relief of symptoms of GUS that improve the quality of life for women of postmenopausal age.genitourinary syndromepostmenopausal womenmetabolic therapyquality of lifeгенитоуринарный синдромпостменопаузаметаболическая терапиякачество жизни[Kaunitz A.M, Manson J.E. Management of Menopausal Symptoms. Obstet Gynecol. Author manuscript; available in PMC 2016.][Rahn D.D, Carberry C, Sanses T.V et al. Vaginal Estrogen for Genitourinary Syndrome of Menopause: A Systematic Review. Obstet Gynecol. Author manuscript; available in PMC 2016.][Erekson E.A, Yip S.O, Wedderburn T.S et al. The VSQ: a questionnaire to measure vulvovaginal symptoms in postmenopausal women. Menopause. Author manuscript; available in PMC 2014.][Santoro N, Epperson C.N, Mathews S.B. Menopausal Symptoms and Their Management. Endocrinol Metab Clin North Am. Author manuscript; available in PMC 2016.][Goldstein I, Dicks B, Kim N.N, Hartzell R. Multidisciplinary Overview of Vaginal Atrophy and Associated Genitourinary Symptoms in Postmenopausal Women. Sex Med 2013; 1 (2): 44-53.][Utian W.H, Maamari R. Attitudes and approaches to vaginal atrophy in postmenopausal women: a focus group qualitative study. Climacteric 2014; 17 (1): 29-36.][Wurz G.T, Kao C-J, De Gregorio M.W. Afety and efficacy of ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy due to menopause. Clin Interv Aging 2014; 9: 1939-50.][Nappi R.E, Panay N, Bruyniks N et al. The clinical relevance of the effect of ospemifene on symptoms of vulvar and vaginal atrophy. limacteric 2015; 18 (2): 233-40.][Menopausal Symptoms: Comparative Effectiveness of Therapies Agency for Healthcare Research and Quality - AHRQ Publication N 15-EHC005-EF 2015.][Nappi R.E, Palacios S, Panay N et al. Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey. Climacteric 2016; 19 (2): 188-97.][Brotman R.M, Shardell M.D, Gajer P et al. Gravitt Association between the vaginal microbiota, menopause status and signs of vulvovaginal atrophy. Menopause. Author manuscript; available in PMC 2015.][Nappi R.E, Biglia N, Cagnacci A et al. Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group. Gynecol Endocrinol 2016; 32 (8): 602-6.][Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. Menopause 2013; 20 (9): 888-902. PMID: 23985562.][Радзинский В.Е., Хамошина М.Б., Мельникова Г.Г. Современный подход к терапии и профилактике метаболических нарушений, связанных с хирургической менопаузой. Доктор. Ру. Гинекология. Эндокринология. Ч. 1. Гинекология. 2009; 50 (6): 21-7.][Mirkin S, Pickar J.H. Management of osteoporosis and menopausal symptoms: focus on bazedoxifene/conjugated estrogen combination. J Womens Health 2013; 5: 465-75.][Kim H-K, Kang S-Y, Chung Y-J et al. The Recent Review of the Genitourinary Syndrome of Menopause. J Menopausal Med 2015; 21 (2): 65-71.][Коваленко И.И., Аталян А.В. Опыт применения гидролизата плаценты у женщин в перименопаузе // Гинекология. 2016; 18 (5): 20-5.][Глазунова А.В., Юренева С.В. Распространенность вульвовагинальной атрофии и ее влияние на качество жизни женщин. Вопросы терминологии и безопасности локальной гормональной терапии. Акушерство и гинекология. 2014; 11: 29-33.][Радзинский В.Е., Хамошина М.Б., Шестакова И.Г. Менопаузальный синдром - терапия и профилактика: доказанные возможности фитоэстрогенов. Доктор. Ру. Гинекология. Эндокринология. 2015; 115 (14): 32-7.][Сычева Е.Г., Аполихина И.А. Коррекция эстроген - дефицитных состояний у женщин с урогенитальными расстройствами. Акушерство и гинекология. 2015; 4: 75-9.][Drain A, Khan A, Ohmann E.L et al. Use of Concomitant Stress Incontinence Surgery at Time of Pelvic Organ Prolapse Surgery Since Release of the FDA Health Notification on Serious Complications Associated with Transvaginal Mesh. J Urol 2016; Nov 17.][Panay E.N. Reating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition? Climacteric 2016; 19 (2): 151-61.][Kim J.H. Действие экстракта человеческой плаценты на симптомы менопаузы, уровни эстрадиола и ФСГ. Сеул, 2008; с. 2-19.][Измайлова Т.Д. Персонализированные протоколы метаболической коррекции как основа anti - age программ. Инъекционные методы в косметологии. 2016; 1: 24-37.][Bruyniks N, Nappi R.E, Castelo-Branco C et al. Effect of ospemifene on moderate or severe symptoms of vulvar and vaginal atrophy. Climacteric 2016; 19 (1): 60-5.][Kingsberg S.A, Krychman M.L. Resistance and barriers to local estrogen therapy in women with atrophic vaginitis. J Sex Med 2013; 10 (6): 1567-74. PMID: 23534861.][Al-Baghdadi O, Ewies A.A. Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up - to - date overview. Climacteric 2009; 12 (2): 91-105.][Mac Bride M.B, Rhodes D.J, Shuster L.T. Vulvovaginal Atrophy. Mayo Clin Proc 2010; 85 (1): 87-94.][Goldstein A.T, King M.A. Ospemifene May Not Treat Vulvar Atrophy: A Report of Two Cases. Sex Med 2016; 4 (3): 217-20.]